Autopsy report · NCT01672086

Active Surveillance Post-Approval Atudy of the Stelkast Surpass Acetabular System

“Product is no longer being manufactured and marketed.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 3 years 10 months before it stopped.
• 347 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

StelKast, Inc.

Sponsor type

Industry

Conditions

Survivorship and Long-term Safety and Effectiveness of the Stelkast Surpass Acetabular System

Interventions

Stelkast Surpass Acetabular System implant

Participants

347

Sites

4

Countries

United States

Trials that died the same way

• Oblimersen Sodium & Combination Chemotherapy in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma
  “Manufacturer is no longer making the drug.” (78% match in meaning)
• Radiographic Analysis Using PureGen Versus Autologous Bone in Posterolateral Fusion (PLF)
  “Product no longer on the market” (77% match in meaning)
• The Study for Evaluate of Satety and Dfficacy of Hemostatic Device
  “The company stopped manufacturing the product” (74% match in meaning)
• Care China-Diabetes
  “the product was delisted.” (66% match in meaning)
• Magnetic Muscle Stimulation of Abdominal Muscle
  “Sponsor Discontinued due to business decision.” (61% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.